Asset Allocation

As of March 31, 2025.
Type % Net
Cash -49.04%
Stock 10.98%
Bond 137.3%
Convertible 0.00%
Preferred 2.08%
Other -1.36%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 90.64%    % Emerging Markets: 5.84%    % Unidentified Markets: 3.52%

Americas 79.26%
70.81%
Canada 0.35%
United States 70.46%
8.45%
Argentina 0.06%
Brazil 2.24%
Colombia 0.18%
Peru 0.79%
Venezuela 0.00%
As of March 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 16.99%
United Kingdom 5.55%
10.24%
Austria 0.99%
France 2.38%
Germany 2.16%
Ireland 0.15%
Italy 0.85%
Netherlands 0.24%
Spain 0.89%
Switzerland 0.01%
1.16%
Russia 0.13%
Turkey 0.70%
0.04%
Greater Asia 0.23%
Japan 0.00%
0.00%
0.23%
Singapore 0.23%
0.00%
China 0.00%
Unidentified Region 3.52%

Bond Credit Quality Exposure

AAA 0.21%
AA 0.89%
A 0.91%
BBB 0.92%
BB 5.87%
B 12.87%
Below B 25.51%
    CCC 8.67%
    CC 4.91%
    C 6.58%
    DDD 0.00%
    DD 0.00%
    D 5.35%
Not Rated 13.49%
Not Available 39.33%
Short Term 0.00%
As of March 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical --
Materials --
Consumer Discretionary --
Financials --
Real Estate --
Sensitive --
Communication Services --
Energy --
Industrials --
Information Technology --
Defensive --
Consumer Staples --
Health Care --
Utilities --
Not Classified --
Non Classified Equity --
Not Classified - Non Equity --
No Data Available
View Region Exposure
Start Trial

Bond Sector Exposure

As of March 31, 2025
Type % Net
Government 2.74%
Corporate 26.45%
Securitized 44.18%
Municipal 0.26%
Other 26.37%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
4.83%
Less than 1 Year
4.83%
Intermediate
53.00%
1 to 3 Years
17.16%
3 to 5 Years
17.41%
5 to 10 Years
18.42%
Long Term
40.81%
10 to 20 Years
27.71%
20 to 30 Years
6.96%
Over 30 Years
6.14%
Other
1.36%
As of March 31, 2025
View Bond Maturity Exposure
Start Trial